Transfusion prevention using erythropoietin, parenteral sucrose iron, and fewer phlebotomies in infants born at ≤30 weeks gestation at a high altitude center: a 10-year experience
- 10 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Perinatology
- Vol. 41 (6), 1403-1411
- https://doi.org/10.1038/s41372-021-00945-7
Abstract
Introduction Red blood cell transfusions in infants born at ≤30 weeks gestation are frequent. Erythropoietin therapy reduces transfusions. An increase in hematocrit is an adaptive response at high altitudes but a guaranteed source of iron is necessary for adequate erythropoiesis. Methods A retrospective cohort study was done to compare red blood cell transfusion practices of the 2019 EpicLatino (EPIC) Latin America network database with a single unit at 2650 m above sea level (LOCAL). The data from LOCAL for three time periods were compared over 10 years based on changes in erythropoietin dose and fewer phlebotomies. The number of cases that received transfusions and the total number of transfusions required were compared. Adjustments were made for known risk factors using a multivariate regression analysis. Results Two hundred and twenty-one cases in LOCAL and 382 cases from EPIC were included. Overall basic demographic characteristics were similar. In EPIC a significantly higher rate of infection (28% vs. 15%) and outborn (10% vs. 1%) was found, but less necrotizing enterocolitis (9% vs. 15%) and use of prenatal steroids (62% vs. 93%) than LOCAL (p < 0.05). EPIC patients received more transfusions (2.6 ± 3 vs. 0.6 ± 1 times) than LOCAL (p < 0.001) and received them significantly more frequently (61% vs. 25%). Within the LOCAL time periods, no statistically significant differences were found other than the need for transfusions (1st 32%, 2nd 28%, 3rd 9%, p = 0.005) and the average number of transfusions (1st 0.8 ± 1.6, 2nd 0.7 ± 1.3, 3rd 0.1 ± 0.3, p = 0.004). These differences remained significant after multivariate regression analysis and adjusting for risk variables. Conclusion The combination of erythropoietin, parenteral sucrose iron, fewer phlebotomies during the first 72 h, and delayed umbilical cord clamping seem to reduce red blood cell transfusion needs. This can be extremely important in high altitude units where higher hematocrit is desirable but may also be valuable at sea level.This publication has 52 references indexed in Scilit:
- Graduated effects of high-altitude hypoxia and highland ancestry on birth sizePediatric Research, 2013
- Risk Factors of Transfusion in Anemia of Very Low Birth Weight InfantsYonsei Medical Journal, 2013
- Neonatal anemiaSeminars in Fetal and Neonatal Medicine, 2008
- Heights and haematology: the story of haemoglobin at altitudePublished by Oxford University Press (OUP) ,2007
- Is there a causal relationship between the receipt of blood transfusions and the development of chronic lung disease of prematurity?Medical Hypotheses, 2006
- Erythropoietin Concentrations and Neurodevelopmental Outcome in Preterm InfantsPEDIATRICS, 2006
- Reduction in Red Blood Cell Transfusions Using a Bedside Analyzer in Extremely Low Birth Weight InfantsJournal of Perinatology, 2004
- PRENATAL STEROIDS (PNS) REDUCE ERYTHROCYTE TRANSFUSION IN VERY LOW BIRTH WEIGHT NEONATES ≤ 1500 GM. 1396Pediatric Research, 1996
- Intravenous Iron Administration to Very‐Low‐Birth‐Weight Newborns Receiving Total and Partial Parenteral NutritionJournal of Parenteral and Enteral Nutrition, 1995
- QUANTITATIVE STUDIES ON THE MORPHOLOGY OF RESPIRATORY SURFACES IN AMPHIBIANSCells Tissues Organs, 1965